Invention Grant
- Patent Title: Articles and methods directed to personalized therapy of cancer
-
Application No.: US16983491Application Date: 2020-08-03
-
Publication No.: US11215618B2Publication Date: 2022-01-04
- Inventor: Alexey Vyacheslavovich Stepanov , Dmitry Dmitrievich Genkin , Richard A. Lerner , Alexey Anatolievich Belogurov , Alexander Gabibovich Gabibov , Jia Xie
- Applicant: HESPERIX SA , The Scripps Research Institute
- Applicant Address: CH Viganello; US CA La Jolla
- Assignee: HESPERIX SA,The Scripps Research Institute
- Current Assignee: HESPERIX SA,The Scripps Research Institute
- Current Assignee Address: CH Viganello; US CA La Jolla
- Agency: Entralta P.C.
- Agent James F. Fleming; Peter D. Weinstein
- Priority: RU2017134483 20171004,RU2018112009 20180404,RU2018134321 20181001
- Main IPC: G01N33/574
- IPC: G01N33/574 ; A61K35/17 ; A61K39/00 ; C07K16/28 ; C12Q1/6886 ; G01N33/50 ; G01N33/543
Abstract:
Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
Public/Granted literature
- US20210333282A9 ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER Public/Granted day:2021-10-28
Information query
IPC分类:
